Working on both sides of the bench-to-bedside translation – turning biological discovery into patient care – is a privilege and my passion.
Where I see patients (3)
Selected research
-
Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.
JCO precision oncology
-
The essential chaperone DNAJC17 activates HSP70 to coordinate RNA splicing and G2-M progression.
bioRxiv : the preprint server for biology
-
Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma.
JCO precision oncology
Contact me
Stress-free visits